Off-label drug use increases ADR risk in paediatric patients

被引：0

作者：

机构：

来源：

Reactions Weekly | 2004年 / 1025卷 / 1期

关键词：

Public Health; Paediatric Patient; Drug Reaction; Adverse Drug Reaction; Drug Prescription;

D O I：

10.2165/00128415-200410250-00010

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：5 / 5

相关论文

共 45 条

[41] Citalopram label recognises need for use in some at-risk patients
Reactions Weekly, 2012, 1396 (1) : 2 - 2
[42] The French medicines regulator Afssaps has warned prescribers about the potential non-Hodgkin's lymphoma risk with off-label infliximab
Reactions Weekly, 2006, 1109 (1) : 2 - 2
[43] Antipsychotic Drug Use and the Risk of Venous Thromboembolism in Elderly Patients With Dementia
Schmedt, Niklas
Garbe, Edeltraut
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2013, 33 (06) : 753 - 758
[44] Cardiovascular drug use does not lower the mortality risk in patients with community-acquired pneumonia (CAP)
Reactions Weekly, 2010, 1322 (1) : 2 - 2
[45] Experience of the United Arab Emirates in the use of monoclonal antibody drug sotrovimab in high-risk vaccinated and unvaccinated patients with COVID-19: an observational cohort study
Abdalateef, Sumaya
Al Meheiri, Noor Majed
Nassef, Mohamed
Shorrab, Ahmed A.
Hashimi, Obaid Al Rahman
Allam, Samah
Alnaqbi, Mariam Saif
Al-Rifai, Rami H.
BMJ OPEN, 2023, 13 (01):

← 1 2 3 4 5 →